Jazz Pharmaceuticals plc — Director's Dealing 2020

Jun 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2020-06-05

Reporting Person: Carr Patricia (VP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-05	Ordinary Shares	S	138	$124.0	Disposed	6500	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Includes 138 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2020.